Physician profile
Mario J Leyba
NPI 1689876013
$1,244,946.02
in general payments reported to CMS, 2019-2025
17 companies · $273K in 2025
The $273K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133K · 2020: $40K · 2021: $107K · 2022: $274K · 2023: $213K · 2024: $205K · 2025: $273K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $444K · Travel and Lodging: $105K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $74K · Consulting Fee: $42K · Food and Beverage: $26K · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $443,976.78 |
| Travel and Lodging | $105,077.47 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $74,085.00 |
| Consulting Fee | $42,247.50 |
| Food and Beverage | $25,665.60 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,141,177.59 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| W. L. Gore & Associates, INC. | $72,495.77 | 2019-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Bio-A Tissue Reinforcement |
| Conmed Corporation | $14,704.36 | 2023-2024 | Airseal, Airseal |
| Smith+Nephew, INC. | $6,988.37 | 2022-2025 | Stravix, Stravix Pl, Stravix Mesh |
| Tela Bio, INC. | $3,113.27 | 2019-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Pacira Pharmaceuticals Incorporated | $2,719.73 | 2019-2021 | |
| Davol INC. | $2,372.13 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip |
| Ethicon US, LLC | $542.34 | 2019-2025 | Stratafix, Dermabond |
| Merck Sharp & Dohme LLC | $222.97 | 2019-2025 | Bridion |
| Becton, Dickinson and Company | $129.27 | 2024 | |
| Endogastric Solutions, INC | $119.96 | 2023 | Esophyx |
| Vertex Pharmaceuticals Incorporated | $93.01 | 2024-2025 | |
| Medtronic USA, INC. | $81.58 | 2020 | |
| Covidien Lp | $74.87 | 2019-2020 | |
| Distalmotion US | $67.13 | 2025 | Dexter L6 Robot |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $29.60 | 2025 | Integra, Surgimend, Omnigraft |
| Acell, INC. | $14.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Leyba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.